Journal
STRUCTURAL CHEMISTRY
Volume 32, Issue 5, Pages 2035-2050Publisher
SPRINGER/PLENUM PUBLISHERS
DOI: 10.1007/s11224-021-01765-3
Keywords
Poly(ADP-ribose) polymerase (PARP); Phthalazinone; Quantitative structure activity relationship (QSAR); Docking
Ask authors/readers for more resources
The study identified PARP-1 inhibitors using a combined ligand-based and receptor-based approach, developing a pharmacophore hypothesis and conducting 3D QSAR studies. The hydrogen bond interaction with the carboxyl amide group was found to be crucial for PARP-1 inhibition. Further virtual screening and molecular interaction studies provide insight into potential PARP-1 inhibitors.
Poly(ADP-ribose) polymerase (PARP) belongs to family of nuclear proteins having a critical role in base excision DNA repair system by catalysing the process of poly(ADP-ribosyl)ation leading to cell proliferation. The role of PARP inhibitors as anticancer agents was accepted after the approval of olaparib for the treatment of BRCA mutation-induced ovarian cancer. A combined ligand-based and receptor-based approach has been reported here for identification of PARP-1 inhibitors. Seventy one analogues of phthalazinone and 4-carboxamide benzimidazole showing activities against PARP-1 were used to develop ligand-based pharmacophore hypothesis using PHASE. The five-point pharmacophore hypothesis ADHRR.1031 was developed, and atom-based 3D-QSAR studies were carried. The developed 3D QSAR model has good correlation coefficient value (R-2 = 0.952) and cross validated with correlation coefficient value (Q(2) = 0.764). To further ascertain the structural requirement for PARP-1 inhibition, molecular interaction studies of inhibitors with PARP-1 were carried out by performing docking studies using Glide 5.6. Hydrogen bond interaction with Gly202 and Ser243 is an important interaction observed by the carboxyl amide group. The pharmacophore model depicts the importance of the hydrogen bond donor and acceptor nature of the carboxyl amide group. Further multistage virtual screening was performed to screen molecules with possible PARP-1 inhibition. Initial screening was performed based on pharmacophoric features followed by docking that consisted of HTVS, SP, and XP docking and final optimisation by Prime MM-GBSA calculation. The screened molecules were further scrutinised for their ADME-toxicity properties.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available